UBM DCF Valuation - Ulisse Biomed Spa

Dashboard Market News Investing Ideas Pricing

Watchlist Manager

Watchlist

Price: 0.78 EUR -2.26% Market Closed

Market Cap: €20.3m

	Ulisse Biomed Spa MIL:UBM	IT
	Factset Research Systems Inc NYSE:FDS	US
G	Gorman-Rupp Co NYSE:GRC	US
N	NCR Corp LSE:0K45	US
	Devon Energy Corp NYSE:DVN	US
K	Kohls Corp BMV:KSS	US
	Digital Realty Trust Inc NYSE:DLR	US
	Verisk Analytics Inc NASDAQ:VRSK	US
	Rexel SA OTC:RXLSF	FR
	Easterly Government Properties Inc NYSE:DEA	US
	HeidelbergCement AG XETRA:HEI	DE
	Avis Budget Group Inc NASDAQ:CAR	US
B	Beforepay Group Ltd ASX:B4P	AU
P	PT Trimegah Bangun Persada Tbk IDX:NCKL	ID
S	Sumitomo Chemical Co Ltd TSE:4005	JP
	NX Filtration NV AEX:NXFIL	NL

UBM's DCF value cannot be reliably calculated.

Relative Valuation Wall Street Price Targets

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.